DRMA
#4893
Dermata Therapeutics, Inc. - Common Stock
1.5 0 USD
+0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.74%
Monthly Change
+25.00%
6 month change
+29.31%
Year Change
+4.90%
Previous Close
1.4 6
Open
1.4 8
Low
1.4 8
High
1.5 1
Volume
9
Financials
- Market Capitalization 6.03 M
- Employee 9
- Founded 2014
- CEO N/A
- Website www.dermatarx.com
- Headquarter Delaware, United States
- FIGI BBG011DJT0X2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.28
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4885 |  NCNA NuCana plc - American Depositary Shares | 1.47 USD | -3.92% | -5.16% | +15.75% | -31.63% | 6.12 M USD | ||
| 4887 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.51 USD | -2.71% | -5.64% | -7.04% | +179.51% | 5.94 M USD | ||
| 4894 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.17 USD | -76.39% | -79.52% | -79.76% | -89.24% | 5.32 M USD | ||
| 4897 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.40 USD | -0.23% | -20.58% | +3900.00% | +62.96% | 5.91 M USD |
Frequently asked questions about Dermata Therapeutics, Inc. Common Stock
What is the Dermata Therapeutics, Inc. Common Stock stock price today?
The current price of Dermata Therapeutics, Inc. Common Stock (DRMA) is 1.50. Over the past 24 hours, the stock has changed by +2.74%. Follow the DRMA chart for real-time price dynamics.
What is the stock ticker of Dermata Therapeutics, Inc. Common Stock?
Dermata Therapeutics, Inc. Common Stock trades under the ticker DRMA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Dermata Therapeutics, Inc. Common Stock stock going up?
DRMA has changed by +4.90% over the last week, +25.00% over the last month, and +4.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Dermata Therapeutics, Inc. Common Stock?
Dermata Therapeutics, Inc. Common Stock currently has a market capitalization of 6.03 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Dermata Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Dermata Therapeutics, Inc. Common Stock reported earnings of -0.74 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Dermata Therapeutics, Inc. Common Stock net income for the last quarter?
Dermata Therapeutics, Inc. Common Stock reported net income of -2.97 M for the last quarter. The previous quarter showed -1.85 M, which means net income changed by -60.58%.
How many employees does Dermata Therapeutics, Inc. Common Stock have?
As of the latest available data, Dermata Therapeutics, Inc. Common Stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Dermata Therapeutics, Inc. Common Stock stock?
You can buy Dermata Therapeutics, Inc. Common Stock (DRMA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Dermata Therapeutics, Inc. Common Stock stock?
Investing in Dermata Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DRMA chart and related analysis on metatrader.com as part of your research.